Dr. Nathalie — Biochemistry Editor and Grant Writer
ScienceDocs Biochemistry Editor and Grant Writer Dr. Nathalie is an experienced life science professional with a strong background in basic and translational cancer biology, and technical expertise in molecular and cell biology, and biochemistry.
Nathalie received a first-class BSc honors degree and a PhD in Biochemistry from the University of Warwick (Coventry, UK). Her graduate work involved characterizing the structure-function relationships of castor bean lectins, with the ultimate aim of improving the selectivity and efficacy of immunotoxins as cancer therapeutics. During her post-doctoral training (University of Edinburgh Medical School and Cancer Research UK Edinburgh Center, Edinburgh, UK), Nathalie studied the roles of p53, and key modulators thereof, in epithelial cell plasticity, differentiation, apoptosis, and cell cycle regulation, using embryonic stem cells, primary pancreas culture, established cell lines, and a range of cancer models.
Latterly, Nathalie transitioned to an Instructor/Junior Faculty position at the MD Anderson Cancer Center (Houston, TX, USA). The overarching goal of her research at MD Anderson was to identify and validate novel therapeutic targets and biomarkers for triple-negative breast cancer, a particularly aggressive subtype associated with high mortality. She focused on master regulators and key effectors of the epithelial-mesenchymal transition (EMT) and investigated how their inhibition impacts cancer stem cell traits and metastatic competence. In addition, she collaborated to characterize the epigenetic reprogramming underpinning EMT, and to develop a breast cancer prognostic signature based on the metabolite profiles of epithelial and mesenchymal cells.
During her time at MD Anderson, Nathalie co-authored 3 externally-funded grants (NIH/R01, ACS, METAvivor) and contributed to a funded multidisciplinary MIRA-CPRIT proposal. Throughout her career, she gained considerable experience in developing research proposals for US (NIH Innovator Award, R21, K99, DoD “Era of Hope”, KOMEN, CPRIT) and UK (BBSRC, MRC, CRUK) funding agencies. She co-authored >20 peer-reviewed manuscripts and served as an ad hoc peer-reviewer for 9 scientific journals.
Nathalie is passionate about writing, with a keen eye for detail, and considerable experience of working with non-native English speakers. She can help improve the clarity and flow of your text, highlight key findings to accentuate impact, comment on the scientific content and referencing, pre-empt referee concerns, format as per the target journal’s guidelines, and tailor proposals to the funding call. She welcomes the opportunity to edit manuscripts and proposals on all aspects of oncology, including transcriptional regulation, signal transduction, tumorigenesis, tumor microenvironment, cancer stem cells, EMT, metastasis, and translational research.
To work with Biochemistry Editor Dr. Nathalie, please visit our quote page and request her in the description area.
